Cross‐sectional evaluation found no significant differences between LRRK2‐PD and iPD groups in MDS‐UPDRS III, NMSS, NMSQ, HADS, AES, MoCA and MMSE total scores. This evidence concerns the gene LRRK2 and Parkinson disease.